Bristol Myers Squibb and Pfizer are launching a direct-to-patient program with 40% discount on Eliquis, reducing the monthly cost from $606 to $346 for eligible patients.

A 30-day supply of Eliquis currently has a list price of $606, but would cost $346 per month under the new program, according to a report from the Wall Street Journal. Since its approval in 2012 ...

(Reuters) -Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to cash-paying U.S. patients at a discount to its listed price as ...

Eliquis will be sold directly to U.S. patients for $346/month—over 40% less than its $606 list price. Starting Sept. 8, eligible patients can order Eliquis online with nationwide shipping via ...

Starting September 8, eligible patients can buy Eliquis through the Eliquis 360 Support program for $346 per month, a 43% discount from its current list price of about $606.

Bristol Myers Squibb and Pfizer said they will start selling their blockbuster blood thinner, Eliquis, directly to some patients at a more than 40% discount. The companies' new effort would bypass ...

BMS and Pfizer have established a direct-to-patient online program, Eliquis 360 Support, which offers the blood thinner at a discount price.

Pfizer and Bristol Myers Squibb have launched a direct-to-patient program offering their blood thinner Eliquis at a 40% discount for cash-paying patients. The list price for Eliquis (apixaban) is ...

The drugmakers Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price—a move that follows the Trump administration’s ...

The drugmakers Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price—a move that follows the Trump administration’s ...